Click for best price
Postpemic Era Nonsteroidal AntiInflammatory Drugs NSAIDs Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Segment Research Report 2022?, which aims to sort out the development status and trends of the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) industry at home and abroad, estimate the overall market scale of the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) industry and the market share of major countries, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) industry, and study and judge the downstream market demand of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) through systematic research, Analyze the competition pattern of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), so as to help solve the pain points of various stakeholders in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market?
Novartis
Pfizer
Boehringer Ingelheim
Teva Pharmaceutical
Hospira
Lonza Group
Mylan
Aurobindo Pharma
Dr. Reddy's Laboratories
Actavis
Wuxi Apptec
Zhejiang NHU
Major Type of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Covered in XYZResearch report:
Paracetamol
Ibuprofen
Aspirin
Naproxen
Others
Application Segments Covered in XYZResearch Market
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
(Post-pandemic Era)-Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Segment Research Report 2022 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
94 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market by Value
2.2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type
2.2.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market by Value
2.3 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market by Sales
2.3.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type
2.3.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market by Sales
3. The Major Driver of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry
3.1 Historical & Forecast Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales and Revenue (2018-2028)
3.2 Largest Application for Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Average Price Trend
13.1 Market Price for Each Type of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in US (2018-2022)
13.2 Market Price for Each Type of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Europe (2018-2022)
13.3 Market Price for Each Type of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in China (2018-2022)
13.4 Market Price for Each Type of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Japan (2018-2022)
13.5 Market Price for Each Type of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in India (2018-2022)
13.6 Market Price for Each Type of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Korea (2018-2022)
13.7 Market Price for Each Type of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
15. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Competitive Landscape
15.1 Novartis
15.1.1 Novartis Company Profiles
15.1.2 Novartis Product Introduction
15.1.3 Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 Pfizer
15.2.1 Pfizer Company Profiles
15.2.2 Pfizer Product Introduction
15.2.3 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Boehringer Ingelheim
15.3.1 Boehringer Ingelheim Company Profiles
15.3.2 Boehringer Ingelheim Product Introduction
15.3.3 Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 Teva Pharmaceutical
15.4.1 Teva Pharmaceutical Company Profiles
15.4.2 Teva Pharmaceutical Product Introduction
15.4.3 Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Hospira
15.5.1 Hospira Company Profiles
15.5.2 Hospira Product Introduction
15.5.3 Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 Lonza Group
15.6.1 Lonza Group Company Profiles
15.6.2 Lonza Group Product Introduction
15.6.3 Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 Mylan
15.7.1 Mylan Company Profiles
15.7.2 Mylan Product Introduction
15.7.3 Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 Aurobindo Pharma
15.8.1 Aurobindo Pharma Company Profiles
15.8.2 Aurobindo Pharma Product Introduction
15.8.3 Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 Dr. Reddy's Laboratories
15.9.1 Dr. Reddy's Laboratories Company Profiles
15.9.2 Dr. Reddy's Laboratories Product Introduction
15.9.3 Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 Actavis
15.10.1 Actavis Company Profiles
15.10.2 Actavis Product Introduction
15.10.3 Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
15.11 Wuxi Apptec
15.12 Zhejiang NHU
16. Conclusion
17. Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure 1. Total Sales by Application of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry (Volume)
Figure 2. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2022
Figure 5. US Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, by Type (Million USD) (2018-2028)
Table 4. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, by Type (K Unit) (2018-2028)
Table 5. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Unit) by Application (2018-2028)
Table 6. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Novartis Profiles
Table 61. Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Introduction
Table 62. Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Novartis Strategic initiatives
Table 64. Pfizer Profiles
Table 65. Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Introduction
Table 66. Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. Pfizer Strategic initiatives
Table 68. Boehringer Ingelheim Profiles
Table 69. Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Introduction
Table 70. Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Boehringer Ingelheim Strategic initiatives
Table 72. Teva Pharmaceutical Profiles
Table 73. Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Introduction
Table 74. Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Teva Pharmaceutical Strategic initiatives
Table 76. Hospira Profiles
Table 77. Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Introduction
Table 78. Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Hospira Strategic initiatives
Table 80. Lonza Group Profiles
Table 81. Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Introduction
Table 82. Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Lonza Group Strategic initiatives
Table 84. Mylan Profiles
Table 85. Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Introduction
Table 86. Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. Mylan Strategic initiatives
Table 88. Aurobindo Pharma Profiles
Table 89. Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Introduction
Table 90. Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Aurobindo Pharma Strategic initiatives
Table 92. Dr. Reddy's Laboratories Profiles
Table 93. Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Introduction
Table 94. Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. Dr. Reddy's Laboratories Strategic initiatives
Table 97. Actavis Profiles
Table 98. Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Introduction
Table 99. Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. Actavis Strategic initiatives
Table 101. Wuxi Apptec Profiles
Table 102. Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Introduction
Table 103. Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 104. Wuxi Apptec Strategic initiatives
Table 105. Zhejiang NHU Profiles
Table 106. Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Introduction
Table 107. Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (Unit), Revenue (Million USD) (2018-2022)
Table 108. Zhejiang NHU Strategic initiatives
